A 5-year, $1.3 million grant from the NIH funds an innovative program to help pathologists understand genomics information and serve as primary consultants for physicians and patients in interpreting and acting on this data.
Read More
The POC test market expands with demands related to outcomes, efficiency, data management, integration, and regulatory pressures.
Read More
Familiarize yourself with new products on the market.
Read More
Invivoscribe Technologies, a privately-held life science company, introduces Genection Inc, which provides physicians with a dedicated online platform for global access to the entire clinically-actionable genetic test menu.
Read More
Quanterix and bioMerieux have entered into a strategic agreement that gives bioMerieux worldwide exclusive rights to Quanterix’s Simoa technology in clinical laboratories and for industrial applications.
Read More